References
- Bemal-Pacheco O, Limotai N, Go CL, Fernandez HH. Nonmotor manifestations in Parkinson disease.Neurologist. 2012 Jan;18(1):1–16
- Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.J Neurol Sci. 2011 Nov 15;310(1–2):123–8
- Iodice V, Low DA, Vichayanrat E, Mathias CJ. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences.J Neurol Sci. 2011 Nov 15;310(1–2):133–8.
- Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.Parkinsonism Relat Disord. 2011 Sep;17(8):625–8
- Chen JJ. Pharmacologic safety concerns in Parkinson's disease: facts and insights. Int J Neurosci. 2011;121 Suppl 2:45–52
- Feldstein C, Weder AB. Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients. J Am Soc Hypertens. 2012 (1):27–39
- Seppi K, Weintraub D, Coelho M, Perez-Lloret S, et al The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the nonmotor symptoms of Parkinson's disease.Mov Disord. 2011 Oct;26 Suppl 3:S42–80.